Annual Current Assets
$214.06 M
-$105.16 M-32.94%
December 31, 2023
Summary
- As of February 8, 2025, MRSN annual total current assets is $214.06 million, with the most recent change of -$105.16 million (-32.94%) on December 31, 2023.
- During the last 3 years, MRSN annual current assets has fallen by -$44.52 million (-17.22%).
- MRSN annual current assets is now -32.94% below its all-time high of $319.22 million, reached on December 31, 2022.
Performance
MRSN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$160.56 M
-$8.41 M-4.98%
September 30, 2024
Summary
- As of February 8, 2025, MRSN quarterly total current assets is $160.56 million, with the most recent change of -$8.41 million (-4.98%) on September 30, 2024.
- Over the past year, MRSN quarterly current assets has dropped by -$89.18 million (-35.71%).
- MRSN quarterly current assets is now -49.70% below its all-time high of $319.22 million, reached on December 31, 2022.
Performance
MRSN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
MRSN Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.9% | -35.7% |
| 3 y3 years | -17.2% | -35.7% |
| 5 y5 years | +188.1% | -35.7% |
MRSN Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.9% | +13.3% | -49.7% | at low |
| 5 y | 5-year | -32.9% | +111.3% | -49.7% | +100.0% |
| alltime | all time | -32.9% | +1578.3% | -49.7% | +116.1% |
Mersana Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $160.56 M(-5.0%) |
| Jun 2024 | - | $168.96 M(-9.9%) |
| Mar 2024 | - | $187.54 M(-12.4%) |
| Dec 2023 | $12.00 M(-20.6%) | $214.06 M(-14.3%) |
| Sep 2023 | - | $249.74 M(-15.9%) |
| Jun 2023 | - | $297.09 M(+5.4%) |
| Mar 2023 | - | $281.81 M(-11.7%) |
| Dec 2022 | $15.12 M(-12.2%) | $319.22 M(+6.4%) |
| Sep 2022 | - | $300.04 M(+26.6%) |
| Jun 2022 | - | $237.08 M(-1.8%) |
| Mar 2022 | - | $241.47 M(+27.8%) |
| Dec 2021 | $17.21 M(+16.2%) | $188.90 M(-5.2%) |
| Sep 2021 | - | $199.36 M(-14.6%) |
| Jun 2021 | - | $233.43 M(+0.6%) |
| Mar 2021 | - | $231.95 M(-10.3%) |
| Dec 2020 | $14.82 M | $258.58 M(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $274.93 M(-6.8%) |
| Jun 2020 | - | $294.90 M(+267.3%) |
| Mar 2020 | - | $80.29 M(-20.8%) |
| Dec 2019 | $6.21 M(+48.1%) | $101.33 M(-11.7%) |
| Sep 2019 | - | $114.70 M(-12.9%) |
| Jun 2019 | - | $131.62 M(-6.7%) |
| Mar 2019 | - | $141.07 M(+89.9%) |
| Dec 2018 | $4.20 M(-68.1%) | $74.31 M(-17.5%) |
| Sep 2018 | - | $90.05 M(-11.9%) |
| Jun 2018 | - | $102.19 M(-8.2%) |
| Mar 2018 | - | $111.36 M(-5.3%) |
| Dec 2017 | $13.17 M(+352.0%) | $117.54 M(-14.0%) |
| Sep 2017 | - | $136.72 M(+71.9%) |
| Jun 2017 | - | $79.56 M(-12.1%) |
| Mar 2017 | - | $90.56 M(-11.4%) |
| Dec 2016 | $2.91 M(+76.1%) | $102.17 M |
| Dec 2015 | $1.66 M | - |
FAQ
- What is Mersana Therapeutics annual total current assets?
- What is the all time high annual current assets for Mersana Therapeutics?
- What is Mersana Therapeutics annual current assets year-on-year change?
- What is Mersana Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly current assets year-on-year change?
What is Mersana Therapeutics annual total current assets?
The current annual current assets of MRSN is $214.06 M
What is the all time high annual current assets for Mersana Therapeutics?
Mersana Therapeutics all-time high annual total current assets is $319.22 M
What is Mersana Therapeutics annual current assets year-on-year change?
Over the past year, MRSN annual total current assets has changed by -$105.16 M (-32.94%)
What is Mersana Therapeutics quarterly total current assets?
The current quarterly current assets of MRSN is $160.56 M
What is the all time high quarterly current assets for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly total current assets is $319.22 M
What is Mersana Therapeutics quarterly current assets year-on-year change?
Over the past year, MRSN quarterly total current assets has changed by -$89.18 M (-35.71%)